Illumina, Caliper Strike Co-Marketing Pact | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Caliper Life Sciences and Illumina will co-market Caliper's library sample preparation and analysis and quality control tools with Illumina's genome sequencing platforms, Caliper said today.

Caliper said the firms have signed an agreement covering marketing for its LabChip XT library preparation tool and its LabChip GX quality control platform for use with Illumina's Genome Analyzer and HiSeq2000 systems.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: intellectual property landscape of CRISPR genome editing, and more.

A researcher has been convicted of conspiring to steal genetically engineered rice, Reuters reports.

Harvard Medical School's George Church says a woolly mammoth-elephant hybrid is only a few years away, according to the New Scientist.

Intel is ending its sponsorship of the International Science and Engineering Fair, the New York Times reports.